ArticleKidney medicine2026
Variation in Attitudes to Native Kidney Biopsy Practice in the United States.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: There is substantial variation in kidney biopsy practices within and between countries; however, the reasons for this are unclear due to limited research among large diverse populations. The aim of this study was to explore variations in attitude to the indications and contraindications for native kidney biopsy in the United States (US). Study Design: A case-vignette questionnaire was developed. A propensity-to-biopsy score (0-44) was generated from responses to indications and contraindications, with a higher score indicating an increased likelihood to recommend biopsy. Dissemination of the questionnaire occurred by email, social media, and the National Kidney Foundation. Setting & Participants: A total of 295 nephrologists/fellows from 43 states within the US participated. Exposure: All participants completed an identical questionnaire on kidney biopsy practice. Outcomes: Responses were collected on indications, contraindications, and attitudes to biopsy. Analytical Approach: Anonymized IP addresses were collected for comparison between US states. Data were also collected on the demographics of the individual and the type of institution in which the doctor was based. Results: In an adjusted multiple linear regression analysis, higher propensity-to-biopsy scores were demonstrated in US clinicians who were male, younger and more frequent performers of kidney biopsy ( Limitations: The condensed clinical scenarios may not accurately replicate real-world cases, and clinicians opted in often using social media, so generalizability is limited. Conclusions: Attitudes to kidney biopsy practice in the US are highly variable, and clinician or institutional characteristics do not fully explain these discrepancies. Further research is required to understand the factors that influence clinical decision making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.